The pacbio that I have are filtered through a pipeline with illumina reads. Most pacbio reads were "junked", but the rest were corrected to be HQ reads, so it should be much better in error rate and so on.
Unconfigured Ad
Collapse
X
-
At the moment you can simply align the pacbio reads to the contigs with a tool like MUMmer, and either make scaffolds yourself or feed pairing information to SSPACE or Bambus.
Originally posted by AdrianP View PostThe pacbio that I have are filtered through a pipeline with illumina reads. Most pacbio reads were "junked", but the rest were corrected to be HQ reads, so it should be much better in error rate and so on.
Comment
-
-
With the the amount of information that you've provided so far, the best help I can give you is that, "You need to tweak some parameters."Originally posted by manjari.deshmukh View PostHi all,
Need help. when doing pacbio assembly with SMRT 2.3.0 portal with 10 SMRT cells using HGAP got 245 contigs which is very high. I want to know how to reduce this number to 1 or 2.
If you would like help with an assembly, you would be better off posting a new thread(rather than continue a 2 year old stale thread) with much more information about what you've tried so far.
What is the organism?
What is the expected genome size?
Is it diploid or haploid?
Approximately how much coverage of the genome did 10 SMRTCells get you?
How was the library prepared?
What sequencing chemistry did you use?
Which protocols have you tried running so far?
With what parameters?
Comment
-
-
Hi,
Yes, i should haave posted this in a new thread.
Anyways, i am working on Bacteria whose genome size is approx 6MB. The coverage provided by 10 SMRT cells is 64X. I am using HGAP 3 with mainly default parameters. only changing Genome size and fiddling with subread length.
Thanks and regards,
Manjari
Comment
-
-
@rhall: There is a new thread with some additional information. http://seqanswers.com/forums/showthread.php?t=51427
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
-
by GATTACATLove this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
-
Channel: Articles
07-01-2026, 11:43 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
20 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
||
|
Started by SEQadmin2, 07-09-2026, 10:04 AM
|
0 responses
32 views
0 reactions
|
Last Post
by SEQadmin2
07-09-2026, 10:04 AM
|
||
|
Started by SEQadmin2, 07-08-2026, 10:08 AM
|
0 responses
20 views
0 reactions
|
Last Post
by SEQadmin2
07-08-2026, 10:08 AM
|
||
|
Started by SEQadmin2, 07-07-2026, 11:05 AM
|
0 responses
34 views
0 reactions
|
Last Post
by SEQadmin2
07-07-2026, 11:05 AM
|
Comment